Related Experiment Video
Updated: Feb 13, 2026

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery
Published on: March 4, 2021
A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon
Binita Das1,2, Beth K Neilsen1, Kurt W Fisher1,3
1Eppley Institute, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Abstract:
AMPK is a serine threonine kinase composed of a heterotrimer of a catalytic, kinase-containing α and regulatory β and γ subunits. Here we show that individual AMPK subunit expression and requirement for survival varies across colon cancer cell lines. While AMPKα1 expression is relatively consistent across colon cancer cell lines, AMPKα1 depletion does not induce cell death. Conversely, AMPKα2 is expressed at variable levels in colon cancer cells. In high expressing SW480 and moderate expressing HCT116 colon cancer cells, siRNA-mediated depletion induces cell death. These data suggest that AMPK kinase inhibition may be a useful component of future therapeutic strategies. We used Functional Signature Ontology (FUSION) to screen a natural product library to identify compounds that were inhibitors of AMPK to test its potential for detecting small molecules with preferential toxicity toward human colon tumor cells. FUSION identified 5'-hydroxy-staurosporine, which competitively inhibits AMPK. Human colon cancer cell lines are notably more sensitive to 5'-hydroxy-staurosporine than are non-transformed human colon epithelial cells. This study serves as proof-of-concept for unbiased FUSION-based detection of small molecule inhibitors of therapeutic targets and highlights its potential to identify novel compounds for cancer therapy development.
Insights
AMP-activated protein kinase (AMPK) subunit expression varies in colon cancer cells. Targeting AMPKα2 or inhibiting AMPK with novel compounds shows potential for colon cancer therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- AMP-activated protein kinase (AMPK) is a crucial cellular energy sensor.
- AMPK is a heterotrimer comprising α, β, and γ subunits, with varying roles in cellular processes.
Purpose of the Study:
- To investigate the differential expression and functional significance of AMPK subunits in colon cancer.
- To identify novel small molecules that inhibit AMPK and exhibit selective toxicity towards colon cancer cells.
Main Methods:
- Analysis of AMPK subunit expression across diverse colon cancer cell lines.
- siRNA-mediated depletion of AMPK subunits to assess cell viability.
- Screening of a natural product library using Functional Signature Ontology (FUSION) to identify AMPK inhibitors.
- Assessing the selective toxicity of identified compounds against colon cancer cells versus normal colon epithelial cells.
Main Results:
- AMPKα1 expression is consistent, but its depletion does not cause cell death.
- AMPKα2 expression varies, and its depletion induces cell death in specific colon cancer cell lines (SW480, HCT116).
- FUSION identified 5'-hydroxy-staurosporine as a competitive AMPK inhibitor with preferential toxicity to colon cancer cells.
Conclusions:
- AMPKα2 plays a critical role in colon cancer cell survival.
- AMPK kinase inhibition represents a potential therapeutic strategy for colon cancer.
- FUSION is a valuable platform for discovering novel small molecule inhibitors for cancer therapy development.
Related Concept Videos
Nuclear Fusion
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
The Colonization of Land
Frequency-dependent Selection
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

